Home Archive
Archive
2024 Volume 45 Issue 2  Published: 2024-02-10
    Topic
  • Lingwei MA , Yuanyuan FENG , Xinmeng SUN , Zhiyong WU , Wei ZHANG , Hexia XIA
    doi: 10.13683/j.wph.2024.02.001

    With the failure of ovarian function, the function of other important organs is also gradually decreased. Some perimenopausal women experience physical, mental symptoms or illnesses, which affect their quality of life. Menopausal hormone therapy (MHT) improves and alleviates the symptoms caused by decline or even failure of ovarian function by adding exogenous sex hormones. This paper reviewed the application scope, commonly regimens and the risks and benefits of various sex hormones, including progestogens, estrogens, combined estrogen-progestogens preparations in MHT, in order to provide a reference for drug use in perimenopausal women.

  • Topic
  • Junmin LI , Jialei ZHU , Jing TANG
    doi: 10.13683/j.wph.2024.02.002

    The onset of endometrial cancer and atypical endometrial hyperplasia is gradually becoming younger, and the current childbearing age is generally delayed, which makes these patients have a great demand for fertility sparing treatment. As the second most common gynecological malignancy in China, the standard treatment is total hysterectomy and bilateral adnexectomy, which leads to permanent infertility. Progesterone is effective in the treatment of early-stage endometrial cancer and atypical endometrial hyperplasia without destroying fertility. Screening criteria for these patients have been recommended in guidelines. Oral megestrol acetate and medroxyprogesterone acetate are the most commonly used fertility sparing treatments, levonorgestrel-releasing intrauterine devices, as a local progesterone therapy, can not be ignored. In addition, studies on the combination of progesterone drugs with metformin and gonadotropin releasing hormone agonist are being carried out. Facing the limitations of existing treatment options, it is equally important to actively search for therapeutic and prognostic markers, and explore new treatment methods.

  • Topic
  • Hui ZHAO , Mingming YAN , Qian ZHANG , Xiaoyan QIU , Mingkang ZHONG
    doi: 10.13683/j.wph.2024.02.003
    Objective

    To investigate the association between testosterone replacement therapy (TRT) and serious adverse events, based on the FDA adverse event reporting system (FAERS) database.

    Method

    Reporting odds ratio (ROR) and Bayesian confidence propagation neural network were applied to analyze the adverse reaction reports in FAERS database from January 2004 to June 2023.

    Result

    A total of 16 702 testosterone users were included according to the including/excluding criteria, and 424 pharmacovigilance signal were detected, among which 155 were strong signals, referring to 29 system organ classes, such as cardiovascular, reproductive, nervous and endocrine systems. The most significant adverse events including polycythemia [ROR 149.10, 95%CI 128.65—172.80, lower limit of information component (IC025) 6.05], testis atrophy (ROR 114.47, 95%CI 89.88—145.79, IC025 4.92), clear cell renal cell carcinoma (ROR 86.97, 95%CI 64.47—117.32, IC025 4.23), and acute myocardial infarction (ROR 20.40, 95%CI 18.77—22.17, IC025 4.14).

    Conclusion

    The serious adverse reactions associated with TRT were mainly thrombosis, serious cardiovascular events and tumor risk, which significantly increased the mortality and disability rate. Health care workers should pay more attention to the potential risk of TRT-related erious adverse events and balance the benefits and risks.

  • Topic
  • Yifan LI , Anni WANG , Xin FENG
    doi: 10.13683/j.wph.2024.02.004
    Objective

    To explore the safety warning signals of dienogest in the FDA adverse event reporting system (FAERS) and to provide reference for clinical safe drug use.

    Methods

    The reports related to dienogest collected from the FAERS database from the first quarter of 2004 to the first quarter of 2022 were searched for adverse event signals by using the reporting odds ratio method in disproportionality analysis. The term set of the International Dictionary of Medical Terms was used for sinicization and analysis.

    Results

    The number of adverse event reports with dienogest as the primary suspect drug was 790 reports with 66 signals. The safety signals were pulmonary embolism after operation, cerebellar stroke, mixed anxiety and depression disorder, Steele's disease and venous embolism. It mainly involves vascular and lymphatic diseases, respiratory system, chest and mediastinal diseases, various injuries, poisoning and operational complications.

    Conclusion

    The FAERS database can be used to comprehensively analyze and study the adverse events of dienogest after marketing, and provide a basis for safe and rational clinical drug use. When using dienogest in clinic, we should pay close attention to the vascular and lymphatic diseases of the drug, and take intervention measures as soon as possible to ensure the safe and effective use of the drug.

  • Article
  • Yongyi XIE , Xin MA , Junwen ZENG , Xiaoxiang XU , Dan DENG , Yeqiang LIU
    doi: 10.13683/j.wph.2024.02.005
    Objective

    To explore the establishment of a human-derived xenograft mouse model for giant congenital melanocytic nevus (GCMN).

    Methods

    Skin from GCMN patients was transplanted onto the backs of two mice with severe combined immunodeficiency, which were then removed after 4 weeks of pressure bandaging. The survival and histopathological characteristics of the transplanted GCMN skin were observed.

    Results

    Mouse No.1 died at 1 week after operation, which may be related to overlarge graft area. Mouse No.2 survived for a long time. The skin xenograft was stable for at least 28 weeks. There was no scar formation at the junction of grafted skin and normal mouse skin. HE staining at GCMN site showed that there were epithelioid nevus cells and melanin granules in the dermis, and immunohistochemistry showed that melanin antigen, microphthalmia transcription factor, S-100 protein, Sry-related HMG-BOX gene 10 were all positive.

    Conclusion

    The human-derived xenograft mouse model of GCMN constructed by this method can maintain the histological features and important molecular phenotypes of GCMN. Meanwhile, the transplanted skin can survive for a long time, which can be used for subsequent basic experiments, and is conducive to the further investigation of the pathogenesis of GCMN and its potential drug development.

  • Article
  • Xiaona TONG , Ruixiang CHEN , Li GUI , Wei CHEN
    doi: 10.13683/j.wph.2024.02.006
    Objective

    To investigate the effects of flavonoids from moringa oleifera leaf on lipid metabolism in HepG2 cells and its potential mechanism.

    Methods

    HepG2 cell model with lipid deposition was constructed, and the cells were treated with moringa leaf flavonoids (final concentration 1, 2, 5, 10μg/ml). Cell counting kit (CCK-8) assay was used to detect cell viability. Oil red O staining was used to detect intracellular lipid droplet staining. The expression of reactive oxygen species (ROS) and adenosine triphosphate (ATP) were detected by the kit. The expression of lipid metabolism-related genes [low-density lipoprotein receptor (LDLR), sterol regulatory component binding protein-1C (SREBP-1C), caveolin-1 (CAV1) and acetyl coenzyme a acetyltransferase 1 (ACAT1)] were detected by quantitative real time polymerase chain reaction. The expression levels of nuclearfactor-E2-relatedfactor (Nrf) 2/hemeoxygenase (HO)-1 signaling pathway were detected by western blot.

    Results

    The cells treated with 1, 2, 5μg/ml of moringa leaf flavonoids were selected for the experiment. Compared with model group, the levels of ROS, SREBP-1c and ACAT1 in HepG2 cells in moringa leaf flavonoids treatment group were significantly decreased, while the levels of ATP, LDLR, CAV1 and Nrf2 and HO-1 protein expressions were significantly increased in a dose-dependent manner, with statistically significant differences (P<0.05). Inhibition of Nrf2/HO-1 signaling pathway reversed the regulatory effect of moringa leaf flavonoids on lipid metabolism related genes expression.

    Conclusion

    Moringa oleifera leaf flavonoids can improve oxidative stress and lipid metabolism in lipid-deposited HepG2 cells, possibly through activation of Nrf2/HO-1 signaling pathway.

  • Article
  • Aimin ZHU , Xiaohong XU , Qiuxiang CHEN , Xia MI , Ce ZHANG , Chi ZHANG
    doi: 10.13683/j.wph.2024.02.007
    Objective

    To explore the effect of roxadustat on anemia and cardiac function in patients with maintenance peritoneal dialysis (MPD).

    Methods

    A total of 90 patients with renal anemia receiving MPD who were regularly followed up for at least 3 months in the Peritoneal Dialysis Center of our hospital from January 2019 to December 2022 were selected and divided into control group and observation group, with 45 cases in each group. The control group was given subcutaneous injection of erythropoietin, and the observation group was given oral roxadustat capsule for 16 weeks. Anemia indexes [red blood cell (RBC), hemoglobin (Hb), hematocrit (Hct)], iron metabolism indexes [transferrin (TRF), total iron binding capacity (TIBC), serum iron, serum ferritin (SF), hepcidin (Hepc)], and cardiac function indexes [brain natriuretic peptide (BNP), left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD)] were collected and compared.

    Results

    After treatment, RBC, Hb and Hct in both groups were significantly improved compared with before treatment (P<0.05), and anemia indexes in observation group were higher than those in the control group (P<0.05). The levels of TRF, TIBC, serum iron and SF in the observation group were higher than those in the control group (P<0.05), and the level of Hepc in the observation group was lower than that in the control group (P<0.05). Compared with control group, BNP level in observation group was significantly decreased (P<0.05). LVEDD and LVESD decreased in the observation group, but the difference was not statistically significant (P>0.05).

    Conclusion

    Roxadustat can obviously improve anemia in MPD patients, and has a certain effect on cardiac function.

  • Article
  • Boran DU , Xiangjun SHI , Xueyan ZHANG , Ran WANG , Chenghong YIN , Xin FENG
    doi: 10.13683/j.wph.2024.02.008
    Objective

    To operate a rapid health technology assessment for treatment of endometriosis with dienogest, providing evidence for clinical evaluation and decision-making.

    Methods

    The researches of dienogest on endometriosis were searched in Pubmed, Embase, CNKI, Wanfang and other databases. AMSTAR, OQAQ and CHEERS (2022) were used to evaluate the methodological quality of health economics, and the treatment of endometriosis with dienogest was comprehensive evaluated.

    Results

    The comprehensive evaluation results showed that dienogest had obvious advantages in preventing recurrence rate and improving pain after endometriosis surgery compared with expectant treatment, and was comparable to gonadotrophin releasing hormone analogue (GnRH-a). On safety evaluation, compared with other therapeutic drugs, dienogest had a higher risk of vaginal bleeding, and the risk of headache and weight gain also should be noted, while the risk of hot flashes, vaginal dryness and osteoporosis was relatively small. From perspective of medical insurance payment, dienogest was more cost-effective compared with GnRH-a, but had no advantage compared with combined oral contraceptives (COC).

    Conclusion

    Dienogest could be used as a long-term maintenance treatment after endometriosis surgery. However, compared with other treatments such as GnRH-a and COC, the efficacy, safety, and pharmacoeconomics of dienogest should be further explored.

  • Article
  • Haiyu XU , Hao YAN , Liming LIU , Jiayu QIU , Wei CHENG
    doi: 10.13683/j.wph.2024.02.009
    Objective

    To evaluate the efficacy and cost of Xihuang pill combined with chemotherapy in the treatment of breast cancer by cost-effectiveness analysis based on the meta-analysis, and to provide reference for clinical optimization of health resource allocation.

    Methods

    Xihuang Pill and chemotherapy were the treatment group, and conventional chemotherapy were the control group. According to the Cocharane system evaluation, RevMan5.4 software was used to conduct meta-analysis and count the costs of two groups. Cost-effectiveness and sensitivity analysis were performed by comparing the differences in efficacy and costs.

    Results

    A total of 7 randomized controlled trials were included in the article. According to the results of meta-analysis, the difference in the effective rate of Xihuang pill combined with chemotherapy compared with the control group was statistically significant (P<0.05), and the clinical effective rate and safety were higher and the recurrence rate was lower compared with the control group. Meanwhile, the results of cost-effectiveness analysis showed that the cost-effectiveness ratio of Xihuang pill combined with cyclophosphamide+Doxorubicin hydrochloride (Adriamycin)+fluorouracil (CAF) regimen was ¥101.07, and the cost-effectiveness ratio of Xihuang pill combined with cyclophosphamide+Epirubicin+fluorouracil (CEF) regimen was ¥64.54, both of which was lower than that of the control group. And the incremental cost effectiveness ratio values of the two scenarios were ¥59.97 and ¥48.13, respectively, which indicated that the Xihuang pill combined with CAF and CEF regimen had a greater cost-effectiveness advantage. The cost-effectiveness of Xihuang pill combined with other programs was not obvious.

    Conclusion

    Xihuang pill combined with CAF and CEF regimen is more economical in the treatment of breast cancer, and is the preferred treatment scheme.

  • Article
  • Aiqiao GENG , Wenjing JIANG , Zhifang ZHANG
    doi: 10.13683/j.wph.2024.02.010
    Objective

    To investigate the effects of antenatal corticosteroid (ACS) therapy on neonatal respiratory distress syndrome (NRDS) in late preterm infants.

    Methods

    Medical records of late preterm infants whose gestational age was 34 weeks≤age<37 weeks, from June 2019 to June 2022 were retrospectively analyzed. According to whether the use of ACS was standardized to promote fetal lung maturation, they were divided into normative group (n=71) and non-normative group (n=79), NRDS in normative group (n=27) and NRDS in non-normative group (n=36). The effects of ACS on the incidence of NRDS, invasive ventilation time, non-invasive ventilation time, hospital stay, hospitalization costs, the use of pulmonary surfactant (PS) and complications were analyzed.

    Results

    The gestational age of normative group was higher than that of non- normative group, and the difference was statistically significant (P<0.05). The occurrence of NRDS in the normative group was larger than that in the non- normative group (P<0.05), and the number of PS users, invasive ventilation time and hospitalization costs were decreased (P<0.05), and the incidence of intracranial hemorrhage was decreased (P<0.05).

    Conclusion

    Although the standard use of ACS can't reduce the incidence of NRDS, but it can improve the condition of children, reduce the use of PS, invasive ventilation time and hospitalization costs, reduce the incidence of intraventricular hemorrhage, and do not increase the incidence of other complications.

  • Article
  • Jing LIN , Fahua SHI , Xiaofei WANG
    doi: 10.13683/j.wph.2024.02.011
  • Review
  • Linjun CAI , Jing LEI , Wenfei LIU , Yingying QIAN , Jiyong MA
    doi: 10.13683/j.wph.2024.02.012

    Copper is involved in many life processes, and imbalance of copper homeostasis leads to cell death, a process known as copper death. Tumor cells maintained higher cellular activity and higher copper load. Copper carriers and related drugs can induce copper overload in tumor cells and lead to copper death of tumor cells. This article reviewed the relationship between copper death and cancer and the anticancer mechanism of copper carrier drugs.

  • Review
  • Meiqi CHEN , Shupan FAN , Yunyun YANG , Juan WANG , Li LIU , Zhuo WANG
    doi: 10.13683/j.wph.2024.02.013

    Prostate cancer (PCa) is one of the most common malignancies in men, and due to its high heterogeneity and drug resistance, general treatment cannot provide maximum benefit to patients.. The prostate development of rodents is quite different from that of human. The existing 2 dimensional model cannot reproduce the unique characteristics of PCa patients. The appearance of in vitro organoid model provides a new idea for PCa research, and bridges the gap between 2 dimensional culture and in vivo model. This paper reviewed describes some existing prostate models, including 2 dimensional cell line models, patient-derived xenotransplantation models (organoid models derived from patients, circulating tumor cell, induced pluripotent stem cells) and organoid models derived from patient-derived xenotransplantation, outlined their advantages and disadvantages in the application.

  • Review
  • Baixue DONG , Yi REN , Jing YANG
    doi: 10.13683/j.wph.2024.02.014

    Diabetes mellitus (DM) has always been one of the major global public health issues. Insulin has been an irreplaceable drug for controlling blood sugar in DM patients for a long time. In order to obtain better hypoglycemic effect and improve patient compliance, insulin preparations are constantly updated and iterated. This article reviewed the research progress in weekly basal insulin, oral insulin administration route and insulin compound preparation, in order to provide reference for clinical practice.

  • Review
  • Jiayi XU , Yuehua BAO , Yigang TONG , Shan YE
    doi: 10.13683/j.wph.2024.02.015

    Graft-versus-host disease (GVHD) is the most significant complication after allogeneic stem cell transplantation. Hormone drugs are the first choice for the treatment of GVHD, but they have limitations in clinical use. This paper reviewed the new GVHD therapeutic drugs and those under development, to provide a reference for clinical use.

  • Review
  • Fengnian GUO , Yuan ZHAO , Jun HE , Weigen LU
    doi: 10.13683/j.wph.2024.02.016

    Neonatal respiratory distress syndrome (NRDS) is a neonatal respiratory disease caused by insufficient secretion of pulmonary surfactant (PS) due to immature lung tissue, it can cause progressive dyspnea, respiratory failure and other lung symptoms. PS replacement therapy is widely used in clinical practice to treat NRDS. With the deepening of related studies and the continuous enrichment of clinical medication knowledge, more and more clinical optimal drug delivery routes of PS have been reported. This article reviewed the clinical application of PS in NRDS and summarized the latest research results of new PS, administration route, administration timing, administration dose, and administration device, and also discussed the possibility application of PS in other respiratory diseases, to provide the reference for improving the level of clinical application of PS.

  • Review
  • Shanshan TANG , Yufan WANG
    doi: 10.13683/j.wph.2024.02.017

    Insulin plays an important role in the treatment of diabetes mellitus (DM). With the prolongation of the continuous action time of insulin analogues and the decrease of the variability of the drug effect, the long-acting basic insulin came into being. In order to seek better basic insulin that is conducive to blood glucose control and improve long-term clinical outcomes, while maximizing patient compliance and treatment continuity, eliminating barriers to initial insulin therapy, and without increasing the risk of hypoglycemia, it is imperative to develop weekly basal insulin. This article focused on the two most advanced weekly basal insulin, and reviewed their molecular structure, pharmacokinetics and published clinical study data for clinical application.

  • Review
  • Chunxia REN , Xiaochun FU , Tingting WU , Rong ZHOU , Zicheng YU
    doi: 10.13683/j.wph.2024.02.018

    Patients with advanced chronic kidney disease (CKD) have a higher risk of venous thromboembolism and atrial fibrillation and need to receive anticoagulant therapy. At the same time, patients with advanced CKD also have an increased risk of bleeding, which complicates antithrombotic therapy. Therefore, special attention should be paid to the rational selection and use of anticoagulant drugs in advanced CKD patients. The application of novel oral anticoagulant in advanced CKD patients is noteworthy because of the rapid effect, short half-life and no need for laboratory indicator monitoring.

  • Pharmacy administration
  • Bo SHU , Yanfei JIANG , Guanghua CHEN , Tingting XING
    doi: 10.13683/j.wph.2024.02.019
    Objective

    To establish the evaluation rules of drug utilization for Shenmai injection, and to explore the application of analytic hierarchy process model (AHM) weighting combined with technique for order preference by similarity to solution (TOPSIS) method in the evaluation of drug utilization rationality of Shenmai injection.

    Methods

    Based on the instructions of Shenmai injection and relevant guidelines, the evaluation criteria for drug utilization of Shenmai injection were established. The rationality of the use of Shenmai injection in 220 patients in the Affiliated Hospital of North Sichuan Medical College (hereinafter referred to as 'our hospital') from January 2022 to December 2022 was retrospectively evaluated by AHM combining with TOPSIS.

    Results

    There were 6 cases (2.73%) with reasonable medication (Ci≥0.8), 185 cases (84.09%) with basically reasonable medication (0.6≤Ci<0.8), and 35 cases (15.91%) with unreasonable medication (Ci<0.6) among the 220 medical records. Disease diagnosis, solvent selection, drug concentration, special population, ADR monitoring and treatment, precautions and course records were the main factors leading to irrational use of Shenmai injection.

    Conclusion

    The evaluation results obtained by AHM weighting combined with TOPSIS method are quantitative, scientific and credible, and can be used to evaluate the rationality of drug use of Shenmai injection.

  • Pharmacy administration
  • Anni WANG , Yifan LI , Xin FENG
    doi: 10.13683/j.wph.2024.02.020
    Objective

    To explore the influence of clinical pharmacists on the level of knowledge, attitude, practice (KAP) in patients with threatened abortion.

    Methods

    Patients with threatened abortion in the obstetrics clinic of our hospital from March 2020 to August 2020 were selected as the baseline group (386 cases). Patients with threatened abortion in the obstetrics clinic of our hospital from March 2021 to August 2021 were selected as the popular science intervention group (321 cases). The intervention group received medication education and guidance from clinical pharmacists on the popularization of threatened abortion and related drug popularization intervention manuals. The KAP level of the two groups was evaluated by the questionnaire on knowledge, attitude and practice of safe medication behavior of pregnant women. The score difference between the two groups was compared, and the factor analysis was used to explore the key issues affecting the KAP level.

    Results

    The total questionnaire scores of baseline group and popular science intervention group were (87.75±8.65) pionts and (101.29±12.69) pionts, respectively. In the baseline group, the average score of knowledge was (24.63±4.42) pionts, the average score of attitude was (29.68±4.65) pionts, and the average score of behavior was (33.44±6.78) pionts, which was lower than the (27.65±5.44), (34.15±6.22) and (39.49±7.00) pionts of the popular science intervention group.

    Conclusion

    The awareness of drugs in the popular science intervention group was significantly higher than that in the baseline group, suggesting that the comprehensive management mode of pharmaceutical intervention by clinical pharmacists could improve the level of KAP in patients with threatened abortion.

News